Efficacy and safety of PARP inhibitors in older patients with advanced ovarian cancer: a systematic review and network meta-analysis - Quiz - MDSpire

Efficacy and safety of PARP inhibitors in older patients with advanced ovarian cancer: a systematic review and network meta-analysis

  • By

  • Lei Liang

  • Bo Yang

  • Yuanyuan Wu

  • Jing-Lei Liu

  • Rongna Liu

  • Li Sun

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of PARP inhibitors in older patients with advanced ovarian cancer: a systematic review and network meta-analysis

  • by Lei Liang, Bo Yang, Yuanyuan Wu, Jing-Lei Liu, Rongna Liu, Li Sun

  • July 9, 2026

Related Content

RHOA at the intersection of inflammation-driven and sporadic colorectal cancer

Unraveling the role of PPFIA1 in cancer: a comprehensive multi-omics analysis and functional validation from pan-cancer to pancreatic cancer

Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says